Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | POLB | P06746 | 3/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | ACMSD | Q8TDX5 | 8/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.47 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32688120 | 0.89 | ACMSD (0.72) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL32688052 | 0.87 | MEN1 (0.56) | MEN1POLBKMT2AACMSDLMNA | |
| SCHEMBL20339582 | 0.84 | KMT2A (0.64) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL32688017 | 0.84 | ACMSD (0.56) | MEN1POLBKMT2AACMSDTNF | |
| SCHEMBL20339424 | 0.81 | MEN1 (0.63) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL32688306 | 0.80 | KMT2A (0.59) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL20339992 | 0.79 | KMT2A (0.59) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL30761215 | 0.79 | KMT2A (0.59) | MEN1POLBKMT2AACMSDADORA1 | |
| SCHEMBL32688027 | 0.77 | MEN1 (0.66) | MEN1POLBKMT2AACMSDNPC1 | |
| SCHEMBL32688381 | 0.77 | MEN1 (0.49) | MEN1POLBKMT2AACMSDTNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | MEN1 4353/4885POLB 508/4885KMT2A 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.